
Acadia Healthcare (ACHC) Stock Forecast & Price Target
Acadia Healthcare (ACHC) Analyst Ratings
Bulls say
Acadia Healthcare Co Inc has demonstrated positive momentum in the behavioral health sector, highlighted by a 3% year-over-year increase in specialized admissions due to targeted referral initiatives at underperforming facilities. The company is on track to significantly increase its net PLGL liability to between $145-165 million by the end of 2025, up from $78 million at the close of 2024, indicating strong operational growth and resilience in an evolving regulatory landscape. Additionally, Acadia's strategy includes reducing capital expenditures by $300 million year-over-year in 2026, which is expected to substantially enhance cash flow and position the company favorably for future expansions and acquisitions.
Bears say
Acadia Healthcare Co Inc has lowered its full-year 2025 adjusted EBITDA guidance by $32.5 million to a range of $650-$660 million, citing ongoing volume softness, rate pressure, and higher-than-expected PLGL expenses. This marks a cumulative reduction of $94 million or 13.4% since the initial guidance was set, reflecting persistent challenges in reimbursement rates and demand for services. Additionally, the company's projections for 2026 have been revised downward, anticipating continued EBITDA pressures and elevated operational costs, which could adversely impact long-term profitability and stock valuation.
This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Acadia Healthcare (ACHC) Analyst Forecast & Price Prediction
Start investing in Acadia Healthcare (ACHC)
Order type
Buy in
Order amount
Est. shares
0 shares